Sentinel Diagnostics

Sentinel Diagnostics is a well-established, independent IVD developer and manufacturer based in Italy, with over 40 years of history and a workforce exceeding 200 employees. It operates a diversified portfolio spanning clinical chemistry reagents, patented FIT collection systems, and molecular diagnostic assays, including its STAT-NAT® line of real-time PCR tests. The company is revenue-generating, invests significantly in R&D, and maintains a global distribution network through partnerships and direct sales. Its strategic focus is on innovation, quality, and providing customized OEM solutions to diagnostic partners worldwide.

Diversified IVD platforms: 1) Clinical Chemistry & Immunochemistry reagent design for major analyzers; 2) Patented universal tube for Fecal Immunochemical Testing (FIT); 3) STAT-NAT® (STabilized Amplification Technology) for real-time PCR assays, featuring stabilized, ready-to-use mixes for singleplex and multiplex pathogen detection.

Sentinel competes in a fragmented but top-heavy global IVD market. In molecular diagnostics, it faces giants like Roche, Abbott, Hologic, and bioMérieux. In clinical chemistry and FIT, competitors include Siemens Healthineers, Beckman Coulter, and Ortho Clinical Diagnostics, as well as specialized FIT companies like Eiken Chemical. Its competitive edge lies in its agility, customization capabilities, patented FIT technology, and focus on stabilized, user-friendly molecular assays.